JP2024525687A5 - - Google Patents
Info
- Publication number
- JP2024525687A5 JP2024525687A5 JP2024501518A JP2024501518A JP2024525687A5 JP 2024525687 A5 JP2024525687 A5 JP 2024525687A5 JP 2024501518 A JP2024501518 A JP 2024501518A JP 2024501518 A JP2024501518 A JP 2024501518A JP 2024525687 A5 JP2024525687 A5 JP 2024525687A5
- Authority
- JP
- Japan
- Prior art keywords
- linear polymer
- particle according
- polymer linker
- thiolated
- multifunctional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221498P | 2021-07-14 | 2021-07-14 | |
| US63/221,498 | 2021-07-14 | ||
| PCT/IL2022/050753 WO2023286060A1 (en) | 2021-07-14 | 2022-07-13 | Brain permeable multifunctional system and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525687A JP2024525687A (ja) | 2024-07-12 |
| JP2024525687A5 true JP2024525687A5 (https=) | 2025-08-13 |
Family
ID=84920126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501518A Pending JP2024525687A (ja) | 2021-07-14 | 2022-07-13 | 脳透過性多機能システム及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240293561A1 (https=) |
| EP (1) | EP4370163A4 (https=) |
| JP (1) | JP2024525687A (https=) |
| CN (1) | CN118043083A (https=) |
| AU (1) | AU2022312222A1 (https=) |
| CA (1) | CA3225403A1 (https=) |
| IL (1) | IL310109A (https=) |
| WO (1) | WO2023286060A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL296303A (en) | 2020-03-15 | 2022-11-01 | Nanocarry Therapeutics Ltd | Nanoscale transfer systems and their medical and diagnostic uses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130177523A1 (en) * | 2010-07-13 | 2013-07-11 | University Of Utah Research Foundation | Gold particles and methods of making and using the same in cancer treatment |
| EP2753360B1 (en) * | 2011-09-07 | 2017-04-26 | Midatech Ltd | Nanoparticle-peptide compositions |
| WO2014185964A1 (en) * | 2013-05-14 | 2014-11-20 | California Institute Of Technology | Method of delivering therapeutics and imaging agents by nanoparticles that cross the blood brain barrier |
| US11000597B2 (en) * | 2015-01-21 | 2021-05-11 | University Of Florida Research Foundation, Incorporated | Engineered receptor/ligand system for delivery of therapeutic agents |
| GB2541166A (en) * | 2015-07-24 | 2017-02-15 | Midatech Ltd | Nanoparticle-based liver-targeting therapy and imaging |
| US20220409743A1 (en) * | 2019-12-23 | 2022-12-29 | Universität Regensburg | Virus-mimetic nanoparticles |
| IL296303A (en) * | 2020-03-15 | 2022-11-01 | Nanocarry Therapeutics Ltd | Nanoscale transfer systems and their medical and diagnostic uses |
-
2022
- 2022-07-13 JP JP2024501518A patent/JP2024525687A/ja active Pending
- 2022-07-13 US US18/578,403 patent/US20240293561A1/en active Pending
- 2022-07-13 WO PCT/IL2022/050753 patent/WO2023286060A1/en not_active Ceased
- 2022-07-13 IL IL310109A patent/IL310109A/en unknown
- 2022-07-13 CN CN202280061871.7A patent/CN118043083A/zh active Pending
- 2022-07-13 EP EP22841615.2A patent/EP4370163A4/en active Pending
- 2022-07-13 AU AU2022312222A patent/AU2022312222A1/en active Pending
- 2022-07-13 CA CA3225403A patent/CA3225403A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11299509B2 (en) | Trigger-activatable sugar conjugates for cancer-selective labeling and targeting | |
| JP5175723B2 (ja) | 単球介在性疾患を治療するための組成物の調製 | |
| DE69719529T2 (de) | Nichtantigenes toxinkonjugat und fusionsprotein eines internalisierendes rezeptorsystems | |
| JP2002543111A (ja) | ポリマーを使用する葉酸で仲介された腫瘍細胞へのターゲッティングの増幅 | |
| AU2009251223B2 (en) | Aprotinin and Analogs as Carriers Across the Blood-Brain Barrier | |
| AU2004240248B2 (en) | Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 | |
| US20090004118A1 (en) | Multifunctional Nanoparticle Conjugates And Their Use | |
| JP2003506319A (ja) | ビタミンに関連したデュアルターゲッティング治療法 | |
| JP2022505171A5 (https=) | ||
| JP2024501894A5 (https=) | ||
| JPH08510262A (ja) | Ｇｃｓｆ及びｅｐｏ用ビタミンｂ▲下１▼▲下２▼介在経口デリバリーシステム | |
| TW201834687A (zh) | 抗-cd19類美登醇(maytansinoid )免疫結合物抗體於治療b-細胞惡性症狀之用途 | |
| CA3149263A1 (en) | Targeted dendrimer conjugates | |
| US9446145B2 (en) | Curcumin-antibody conjugates as anti-cancer agents | |
| BR112012001260B1 (pt) | Conjugados de épsilon-polilisina, seu uso, conjugado de macromolécula, e kit | |
| US20110104103A1 (en) | Method of conjugating therapeutic compounds to cell targeting devices via metal complexes | |
| JP2015526435A (ja) | 抗体成分と血液脳関門を通過するポリペプチドと細胞毒とを含むコンジュゲート | |
| JP2024543016A (ja) | トランス－シクロオクテンコンジュゲート | |
| WO2018231661A1 (en) | Methods and reagents to treat tumor and cancer | |
| JP2025501978A5 (https=) | ||
| JP2022543022A (ja) | 抗体‐ポリマー複合体 | |
| JP2024525687A5 (https=) | ||
| AU2020315947A1 (en) | Methods and compositions for treating cancer using peptide nucleic acid-based agents | |
| JP2024515880A5 (https=) | ||
| Yi et al. | Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies |